Completed PHASE3 INTERVENTIONAL 2-arm NCT00388661

Melatonin and Quality of Life in Dialysis Patients

Double Blind Placebo-controlled Study on the Efficacy of Melatonin on Sleep, Resulting in an Improved Quality of Life in Hemodialysis Patients

Sponsor: Dutch Kidney Foundation

Conditions Haemodialysis Sleep Problems

Interventions Melatonin tablet 3 mg once daily Placebo comparator

Updated 6 times since 2017 Last updated: Jul 19, 2011 Started: Apr 30, 2007 Primary completion: Oct 31, 2009 Completion: Dec 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00388661, this PHASE3 trial focuses on Haemodialysis and Sleep Problems and remains completed. Sponsored by Dutch Kidney Foundation, it has been updated 6 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Apr 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dutch Kidney Foundation
Meander Medical Center

Data source: Meander Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Amersfoort, Netherlands
• Haarlem, Netherlands